• Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Consensus Rating of "Moderate Buy" from Analysts

    Source: Buzz FX / 01 Feb 2025 01:51:09   America/Chicago


    Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat February 1, 2025 Share Link copied to clipboard. Madrigal Pharmaceuticals, Inc.
    Read more...
Share on,